Skip to main content

Advertisement

SpringerLink
Log in

Breast Cancer Risk and Follow-up Recommendations for Young Women Diagnosed with Atypical Hyperplasia and Lobular Carcinoma In Situ (LCIS)

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The risk of breast cancer in young women diagnosed with atypical hyperplasia and (LCIS) is not well defined. The objectives were to evaluate outcomes and to help determine guidelines for follow-up in this population.

Methods

A retrospective review of women under age 35 diagnosed with ADH, ALH, LCIS, and severe ADH from 1987 to 2010 was performed. Patient characteristics, pathology and follow-up were determined from chart review.

Results

We identified 58 young women with atypical breast lesions. Median age at diagnosis was 31 years (range 19–34). 34 patients had ADH, 11 had ALH, 8 had LCIS, and 5 had severe ADH.

7 (12%) patients developed breast cancer. The median follow-up was 86 months (range 1–298). Median time to cancer diagnosis was 90 months (range 37–231). 4 cancers were on the same side, 3 were contralateral. 4 were IDC, 1 was ILC, and 2 were DCIS.

Cancer was detected by screening mammogram in 4 patients, 2 by clinical exam, and 1 unknown. In the entire cohort, 26 (45%) patients had screening mammograms as part of their follow up, 12 patients had only clinical follow up, and 20 had no additional follow up. 13 patients required subsequent biopsies.

Conclusion

Young women with atypical breast lesions are at a markedly increased risk for developing breast cancer and should be followed closely. Based on our findings, we recommend close clinical follow-up, MRI starting at age 25 through age 29, and screening mammograms for those over 30 in this high-risk group of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Carter CL, Corle DK, Micozzi MS, et al. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol. 1988;128(3):467–77.

    CAS  PubMed  Google Scholar 

  2. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55(11):2698–708.

    Article  CAS  PubMed  Google Scholar 

  3. Page DL, Kidd TE Jr., Dupont WD, et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol. 1991;22(12):1232–9.

    Article  CAS  PubMed  Google Scholar 

  4. Marshall LM, Hunter DJ, Connolly JL, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev. 1997;6(5):297–301.

    CAS  PubMed  Google Scholar 

  5. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312(3):146–51.

    Article  CAS  PubMed  Google Scholar 

  6. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992;267(7):941–4.

    Article  CAS  PubMed  Google Scholar 

  7. Coopey SB, Mazzola E, Buckley JM, et al. The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions. Breast Cancer Res Treat. 136(3):627–33.

  8. Network NCC. Breast Cancer Screening and Diagnosis. Vol. 2014, 2014.

  9. Surveillance E, and End Results (SEER) Program Populations SEER9 Registries. 1973–2011.

  10. Degnim AC, Visscher DW, Berman HK, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol. 2007;25(19):2671–7.

    Article  PubMed  Google Scholar 

  11. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90(18):1371–88.

    Article  CAS  PubMed  Google Scholar 

  12. Vogel VG, Costantino JP, Wickerham DL, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006;295(23):2727–41.

    Article  CAS  PubMed  Google Scholar 

  13. Barthelmes L, Gateley CA. Tamoxifen and pregnancy. Breast 2004;13(6):446–51.

    Article  CAS  PubMed  Google Scholar 

  14. Mainiero MB, Lourenco A, Mahoney MC, et al. ACR appropriateness criteria breast cancer screening. J Am Coll Radiol. 10(1):11–4.

  15. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 2005;23(33):8469–76.

    Article  PubMed  Google Scholar 

  16. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75–89.

    Article  PubMed  Google Scholar 

  17. Port ER, Park A, Borgen PI, et al. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol. 2007;14(3):1051–7.

    Article  PubMed  Google Scholar 

  18. Schwartz T, Cyr A, Margenthaler J. Screening breast magnetic resonance imaging in women with atypia or lobular carcinoma in situ. J Surg Res. 193(2):519–22.

  19. Lee CH, Dershaw DD, Kopans D, et al. Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer. J Am Coll Radiol. 7(1):18–27.

  20. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008;299(18):2151–63.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Disclosure

No disclosures.

Author information

Authors and Affiliations

  1. Department of Surgical Oncology-Breast Surgery Division, Massachusetts General Hospital, Boston, MA, USA

    Maureen P. McEvoy MD, Suzanne B. Coopey MD, Emanuele Mazzola PhD, Julliette Buckley MD, Ahmet Belli MD, Fernanda Polubriaginof MD, Andrea L. Merrill MD, Rong Tang MD, Judy E. Garber MD, Barbara L. Smith MD, PhD, Michele A. Gadd MD, Michelle C. Specht MD, Anthony J. Guidi MD, Constance A. Roche NP & Keven S. Hughes MD

Authors
  1. Maureen P. McEvoy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suzanne B. Coopey MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emanuele Mazzola PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Julliette Buckley MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ahmet Belli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fernanda Polubriaginof MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andrea L. Merrill MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Rong Tang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Judy E. Garber MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Barbara L. Smith MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Michele A. Gadd MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Michelle C. Specht MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Anthony J. Guidi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Constance A. Roche NP
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Keven S. Hughes MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maureen P. McEvoy MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McEvoy, M.P., Coopey, S.B., Mazzola, E. et al. Breast Cancer Risk and Follow-up Recommendations for Young Women Diagnosed with Atypical Hyperplasia and Lobular Carcinoma In Situ (LCIS). Ann Surg Oncol 22, 3346–3349 (2015). https://doi.org/10.1245/s10434-015-4747-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-015-4747-1

Keywords

Search

Navigation